Altimmune Contact Us

Altimmune, Inc.

(240) 654-1450 Oops! Something went wrong, please try again later.Add hoursAdd photosOops! Something went wrong, please try again later.

• Website
• Directions
• Get quote
• Prices

ABOUT US Altimmune Website

WEBABOUT US. Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is …

See Also: Phone Number Preview /  Show details

Altimmune Granted Fast Track Designation by FDA for …

240-654-1450 WEBOct 26, 2023 · US English Select an edition. US English; Phone: 240-654-1450 reisenstadt@altimmune.com. Media Contact: Danielle Cantey Evoke Canale Phone: …

See Also: Phone Number Preview /  Show details

Altimmune Granted Fast Track Designation by FDA for

240-654-1450 WEBOct 26, 2023 · Phone: 240-654-1450 reisenstadt@altimmune.com. Media Contact: Danielle Cantey Evoke Canale Phone: 619-826-4657 [email protected]

See Also: Phone Number Preview /  Show details

Altimmune Granted Fast Track Designation by FDA for …

240-654-1450 WEBOct 26, 2023 · Phone: 240-654-1450 reisenstadt@altimmune.com. Media Contact: Danielle Cantey Evoke Canale Phone: 619-826-4657 …

See Also: Phone Number Preview /  Show details

AdCOVID™, Altimmune’s Single Dose, Intranasal COVID19 …

WEBMar 15, 2021 · Altimmune recently started a Phase 1 clinical trial of AdCOVID and anticipates having a data readout from this trial in the second quarter of 2021. About …

See Also: Databases Preview /  Show details

Altimmune, Inc. Company Profile Gaithersburg, MD Competitors

WEBFind company research, competitor information, contact details & financial data for Altimmune, Inc. of Gaithersburg, MD. Get the latest business insights from Dun & …

See Also: Contact Support Preview /  Show details

Altimmune Inc Company Profile Overview GlobalData

020 7936 6400 WEBAltimmune Inc (Altimmune), is a biopharmaceutical company that includes the development of novel peptide-based therapeutics for the treatment of obesity and liver …

See Also: Databases Preview /  Show details

Altimmune Commences Enrollment in Phase 1 Clinical Trial of …

WEBFeb 25, 2021 · Altimmune anticipates having a full data readout from this Phase 1 study in Q2 2021. “The commencement of our Phase 1 clinical trial of AdCOVID is an important …

See Also: Databases Preview /  Show details

Altimmune Crunchbase Company Profile & Funding

WEBContact Email info@altimmune.com. Phone Number 8555571369. Altimmune is an emerging biotechnology company located in Montgomery County, MD. Altimmune …

See Also: Phone Number Preview /  Show details

Altimmune Announces Positive Topline Results from Markets …

240-654-1450 WEBNov 30, 2023 · Investor Contact: Rich Eisenstadt Chief Financial Officer Phone: 240-654-1450 reisenstadt@altimmune.com. Media Contact: Danielle Duchene Evoke Canale …

See Also: Phone Number Preview /  Show details

Altimmune Announces Positive Lean Mass Preservation Data for

240-654-1450 WEBMar 27, 2024 · Investor Contact: Rich Eisenstadt Chief Financial Officer Phone: 240-654-1450 reisenstadt@altimmune.com. Media Contact: Danielle Cantey Inizio Evoke, …

See Also: Phone Number Preview /  Show details

Altimmune Announces Update on AdCOVID™ Phase 1 Clinical Trial

WEBJune 29, 2021 at 4:01 PM EDT. GAITHERSBURG, Md., June 29, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical …

See Also: Phone Number Preview /  Show details

Altimmune Announces Presentation of Pemvidutide Clinical Data …

WEBJan 2, 2024 · For more information, please visit www.altimmune.com. Follow @Altimmune, Inc. on LinkedIn Follow @AltimmuneInc on Twitter. Investor Contact: …

See Also: Contact Support Preview /  Show details

Altimmune, Inc. (ALT) Company Profile & Overview Stock Analysis

WEB2 days ago · Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product …

See Also: Atm Preview /  Show details

Altimmune Announces Completion of Dosing in the Phase 2 …

240-654-1450 WEBSep 12, 2023 · Altimmune Investor & Media Contact: Rich Eisenstadt Chief Financial Officer Phone: 240-654-1450 reisenstadt@altimmune.com. Follow us on: See also: …

See Also: Phone Number Preview /  Show details

Governor Hochul Launches Grid of the Future Study to Build Clean …

WEB1 day ago · “The Grid of the Future proceeding will help us establish deployment goals and strategies to help meet the State’s nation-leading clean energy goals in a way that …

See Also: Phone Number Preview /  Show details